Similarly, both the depletion of ASC protein and treatment with the MCC950 inhibitors of NLRP3 in Tau Tg mice (carrying the AD-related mutation P301S in the Tau protein) were shown to reduce tau pathology [158]. The gene discussed is MAPT; the disease is Alzheimer disease.